Markers of DNA repair and susceptibility to cancer in humans: An epidemiologic review

Journal of the National Cancer Institute

Volumn 92, Issue 11, 2000, Pages 874-897

  Berwick, Marianne ^a   Vineis, Paolo ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; COMET ASSAY; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; GENETIC VARIABILITY; GENOME; HOST CELL; HUMAN; MICRONUCLEUS TEST; POPULATION; PRIORITY JOURNAL; REVIEW; UNSCHEDULED DNA SYNTHESIS;

EID: 0034616662     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.11.874     Document Type: Review

References (93)

1. Friedberg EC, Walker GC, Siede W. DNA repair and mutagenesis. Washington (DC): ASM Press; 1995.
2. Setlow RB. Variations in DNA repair among humans. In: Harris CC, Autrup HN, editors, Human carcinogenesis, New York (NY): Academic Press; 1983. p. 231-54.
3. Cherry LM, Hsu TC. Bleomycin-induced chromosome damage in lymphocytes of medullary thyroid carcinoma patients and their family members. Anticancer Res 1983;3:367-72.
4. Pero RW, Miller DG, Lipkin M, Markowitz M, Gupta S, Winawer SJ, et al. Reduced capacity for DNA repair synthesis in patients with or genetically predisposed to colorectal cancer. J Natl Cancer Inst 1983;70:867-75.
5. Pero RW, Ritchie M, Winawer SJ, Markowitz MM, Miller DG. Unscheduled DNA synthesis in mononuclear leukocytes from patients with colorectal polyps. Cancer Res 1985;45:3388-91.
6. Hsu TC, Cherry LM, Samaan NA. Differential mutagen susceptibility in cultured lymphocytes of normal individuals and cancer patients. Cancer Genet Cytogenet 1985;17:307-13.
7. Munch-Petersen B, Frentz G, Squire B, Wallevik K, Horn CC, Reymann F, et al. Abnormal lymphocyte response to u.v. radiation in multiple skin cancer. Carcinogenesis 1985;6:843-5.
8. Pero RW, Heim S, Bryngelsson C. Lower rates of thymidine incorporation into DNA of skin fibroblasts from patients with adenomatosis of the colon and rectum. Carcinogenesis 1986;7:541-5.
9. Kovacs E, Stucki D, Weber W, Muller H. Impaired DNA-repair synthesis in lymphocytes of breast cancer patients. Eur J Cancer Clin Oncol 1986; 22:863-9.
10. Roth M, Muller H, Boyle JM. Immunochemical determination of an initial step in thymine dimer excision repair in xeroderma pigmentosum variant fibroblasts and biopsy material from the normal population and patients with basal cell carcinoma and melanoma. Carcinogenesis 1987;8:1301-7.
11. Markowitz MM, Johnson DB, Pero RW, Winawer SJ, Miller DG. Effects of cumene hydroperoxide on adenosine diphosphate ribosyl transferase in mononuclear leukocytes of patients with adenomatous polyps in the colon. Carcinogenesis 1988;9:349-55.
12. Hsu TC, Johnston DA, Cherry LM, Ramkissoon D, Schuntz SP, Jessup JM, et al. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 1989;43:403-9.
13. Pero RW, Johnson DB, Miller DG, Zang E, Markowitz M, Doyle GA, et al. Adenosine diphosphate ribosyl transferase responses to a standardized dose of hydrogen peroxide in the mononuclear leukocytes of patients with a diagnosis of cancer. Carcinogenesis 1989;10:1657-64.
14. 6-methylguanine repair in fibroblast cultures from patients with lung cancer. Cancer Res 1989;49:5623-6.
15. Spitz MR, Fueger JJ, Beddingfield NA, Annegers JF, Hsu TC, Newell GR, et al. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res 1989; 49:4626-8.
16. Schantz SP, Spitz MR, Hsu TC. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst 1990;82:1773-5.
17. Alcalay J, Freeman SE, Goldberg LH, Wolf JE. Excision repair of pyrimidine dimers induced by simulated solar radiation in the skin of patients with basal cell carcinoma. J Invest Dermatol 1990;95:506-9.
18. Kovacs E, Hajto T, Hostanska K. Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador). Eur J Cancer 1991;27:1672-6.
19. Kovacs E, Langemann H. Differences in the kinetics of DNA repair in cancer patients and healthy controls. Oncology 1991;48:312-6.
20. Athas WF, Hedayati MA, Matanoski GM, Farmer ER, Grossman L. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res 1991;51:5786-93.
21. Kovacs E, Langemann H, Ludwig H. Do chemo-and radiotherapy affect the DNA repair ability of lymphocytes? Arch Gynecol Obstet 1992;251:121-6.
22. Pero RW, Olsson H, Killander F, Troll W. Elevation of ADP-ribosylation as an indicator of mononuclear leucocyte responsiveness in breast cancer patients treated with tamoxifen. Eur J Cancer 1992;28A:1803-6.
23. Pero RW, Salford LG, Stromblad LG, Andersson C. Mononuclear leukocyte ADP-ribosylation as an indicator of immune function in malignant-glioma patients treated with betamethasone for cerebral edema. J Neurosurg 1992;77:601-6.
24. Hsu TC, Feun L, Trizna Z, Savaraj N, Shirley LR, Furlong CL, et al. Differential sensitivity among three human subpopulations in response to 4-nitroquinoline-1-oxide and to bleomycin. Int J Oncol 1993;3:827-30.
25. Spitz MR, Fueger JJ, Halabi S, Schantz SP, Sample D, Hsu TC. Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev 1993;2:329-33.
26. 2-phase X irradiation in relation to DNA repair and radiosensitivity in a cancer-prone family with Li-Fraumeni syndrome. Radiat Res 1993;136:236-40.
27. Bondy ML, Spitz MR, Halabi S, Fueger JJ, Schantz SP, Sample D, et al. Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients. Cancer Epidemiol Biomarkers Prev 1993;21:103-6.
28. Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci U S A 1993;90:1614-8.
29. Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L. DNA repair related to multiple skin cancers and drug use. Cancer Res 1994;54: 437-40.
30. Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L. DNA repair and susceptibility to basal cell carcinoma: a case-control study. Am J Epidemiol 1994;140:598-607.
31. Hall J, English DR, Artuso M, Armstrong BK, Winter M. DNA repair capacity as a risk factor for non-melanocytic skin cancer - a molecular epidemiological study. Int J Cancer 1994;58:179-84.
32. Spitz MR, Hoque A, Trizna Z, Schantz SP, Amos CI, King TM, et al. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst 1994;86: 1681-4.
33. Scott D, Spreadborough A, Levine E, Roberts SA. Genetic predisposition in breast cancer [letter]. Lancet 1994;344:1444.
34. Cloos J, Braakhuis BJ, Steen I, Copper MP, de Vries N, Nauta JJ, et al. Increased mutagen sensitivity in head-and-neck squamous-cell carcinoma patients, particularly those with multiple primary tumors. Int J Cancer 1994;56:816-9.
35. Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L. DNA repair capacity for ultraviolet light-induced damage is reduced in peripheral lymphocytes from patients with basal cell carcinoma. J Invest Dermatol 1995;104:933-6.
36. Strom SS, Wu X, Sigurdson AJ, Hsu TC, Fueger JJ, Lopez, J, et al. Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. Natl Cancer Inst Monogr 1995;18:29-33.
37. Ranjit GB, Cheng MF, Mackay W, Whitacre CM, Berger JS, Berger NA. Poly(adenosine diphosphoribose) polymerase in peripheral blood leukocytes from normal donors and patients with malignancies. Clin Cancer Res 1995,1:223-34.
38. Spitz MR, Hsu TC, Wu X, Fueger JJ, Amos CI, Roth JA. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev 1995;4:99-103.
39. Wu X, Delclos GL, Annegers JF, Bondy ML, Honn SE, Henry B, et al. A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 1995;4:583-8.
40. Bondy ML, Kyritsis AP, Gu J, de Andrade M, Cunningham J, Levin VA, et al. Mutagen sensitivity and risk of gliomas: a case-control analysis. Cancer Res 1996;56:1484-6.
41. Wei Q, Gu J, Cheng L, Bondy ML, Jiang H, Hong WK, et al. Benzo(a) pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res 1996;56:3975-9.
42. Wei Q, Cheng L, Hong WK, Spitz MR. Reduced DNA repair capacity in lung cancer patients. Cancer Res 1996;56:4103-7.
43. Parshad R, Price FM, Bohr VA, Cowans KH, Zujewski JA, Sanford KK. Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer 1996;74:1-5.
44. Cloos J, Bongers V, Lubsen H, Tobi H, Braakhuis BJ, Snow GB. Lack of effect of daily N-acetylcysteine supplementation on mutagen sensitivity. Cancer Epidemiol Biomarkers Prev 1996;5:941-1.
45. Cloos J, Steen I, Timmerman AJ, van der Schans GP, Snow GB, Braakhuis BJ. DNA-damage processing in blood lymphocytes of head-and-neck-squamous-cell-carcinoma patients is dependent on tumor site. Int J Cancer 1996;68:26-9.
46. Cloos J, Spitz MR, Schantz SP, Hsu TC, Zhang ZF, Tobi H, et al. Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 1996;88:530-5.
47. Patel RK, Trivedi AH, Arora DC, Bhatavdekar JM, Patel DD. DNA repair proficiency in breast cancer patients and their first-degree relatives. Int J Cancer 1997;73:20-4.
48. Hu JJ, Roush GC, Dubin N, Berwick M, Roses DF, Harris MN. Poly(ADP-ribose) polymerase in human breast cancer: a case-control analysis. Pharmacogenetics 1997;7:309-16.
49. Schantz SP, Zhang ZF, Spitz MS, Sun M, Hsu TC. Genetic susceptibility to head and neck cancer: interaction between nutrition and mutagen sensitivity. Laryngoscope 1997;107:765-81.
50. Jaloszynski P, Kujawski M, Czub-Swierczek M, Markowska J, Szyfter K. Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assay. Mutat Res 1997;385:223-33.
51. Price EA, Bourne SL, Radbourne R, Lawton PA, Lamerdin J, Thompson LH, et al. Rare microsatellite polymorphisms in the DNA repair genes XRCC1, XRCC3 and XRCC5 associated with cancer in patients of varying radiosensitivity. Somat Cell Mol Genet 1997;23:237-47.
52. Wei Q, Eicher SA, Guan Y, Cheng L, Xu J, Young LN, et al. Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer. Cancer Epidemiol Biomarkers Prev 1998;7:309-14.
53. Cheng L, Eicher SA, Guo Z, Hong WK, Spitz MR, Wei Q. Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1998;7:465-8.
54. Moller P, Knudsen LE, Frentz G, Dybdahl M, Wallin H, Nexo BA. Seasonal variation of DNA damage and repair in patients with non-melanoma skin cancer and referents with and without psoriasis. Mutat Res 1998;407: 25-34.
55. Rao NM, Pai SA, Shinde SR, Ghosh SN. Reduced DNA repair capacity in breast cancer patients and unaffected individuals from breast cancer families. Cancer Genet Cytogenet 1998;102:65-73.
56. Wu X, Gu J, Hong WK, Lee JJ, Amos CI, Jiang H, et al. Benzo(a)pyrene did epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst 1998;90:1393-9.
57. Wu X, Hsu TC, Cao S, Lee JJ, Amos CI, Spitz MR. Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk. Carcinogenesis 1998; 19:93-8.
58. Wu X, Gu J, Patt Y, Hassan M, Spitz MR, Beasley RP, et al. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 1998;7:567-70.
59. Wu X, Gu J, Amos CI, Jiang H, Hong WK, Spitz MR. A parallel study of in vitro sensitivity to benzo(a)pyrene diol epoxide and bleomycin in lung carcinoma cases and controls. Cancer 1998;83:1118-27.
60. Spitz MR, Lippman SM, Jiang H, Lee JJ, Khuri F, Hsu TC, et al. Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract. J Natl Cancer Inst 1998;90:243-5.
61. Miller DG, Tiwari R, Pathak S, Hopwood VL, Gilbert F, Hsu TC. DNA repair and mutagen sensitivity in patients with triple primary cancers. Cancer Epidemiol Biomarkers Prev 1998;7:321-7.
62. Sigurdson AJ, Bondy ML, Hess KR, Toms SA, Kyritsis AP, Gu J, et al. Gamma-ray mutagen sensitivity and survival in patients with glioma. Clin Cancer Res 1998;4:3031-5.
63. Wang LE, Sturgis EM, Eicher SA, Spitz MR, Hong WK, Wei Q. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clin Cancer Res 1998;4:1773-8.
64. Udumudi A, Jaiswal M, Rajeswari N, Desai N, Jain S, Balakrishna N, et al. Risk assessment in cervical dysplasia patients by single cell gel electrophoresis assay: a study of DNA damage and repair. Mutat Res 1998;412: 195-205.
65. Leprat F, Alapetite C, Rosselli F, Ridet A, Schlumberger M, Sarasin A, et al. Impaired DNA repair as assessed by the "comet" assay in patients with thyroid tumors after a history of radiation therapy: a preliminary study. Int J Radiat Oncol Biol Phys 1998;40:1019-26.
66. Scott D, Barber JB, Levine EL, Burrill W, Roberts SA. Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br J Cancer 1998;77:614-20.
67. Cleaver JE, Charles WC, McDowell ML, Sadinski WJ, Mitchell DL. Overexpression of the XPA repair gene increases resistance to ultraviolet radiation in human cells by selective repair of DNA damage. Cancer Res 1995; 55:6152-60.
68. Wei Q, Spitz MR, Gu J, Cheng L, Xu X, Strom SS, et al. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. Cancer Epidemiol Biomarkers Prev 1996;5:199-204.
69. Wu X, Zhao Y, Honn SE, Tomlinson GE, Minna JD, Hong WK, et al. Benz[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. Cancer Res 1998;58:1605-8.
70. Wu X, Hsu TC, Annegers JF, Amos CI, Fueger JJ, Spitz MR. A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. Cancer Res 1995;55:557-61.
71. 2-phase lymphocytes as an indicator of cancer predisposition. Radiat Res 1996;145:3-16.
72. Moriwaki SI, Ray S, Tarone RE, Kraemer KH, Grossman L. The effect of donor age on the processing of UV-damaged DNA by cultured human cells: reduced DNA repair capacity and increased DNA mutability. Mutat Res 1996;364:117-23.
73. Stierum RH, Hageman GJ, van Herwijinen MH, van der Veer MS, Kleinjans JC. Age-related negative associations between parameters of cytogenetic damage and ex vivo (+/-) anti-benzo(a)pyrene diolepoxide-induced unscheduled DNA synthesis in smoking humans. Cancer Epidemiol Biomarkers Prev 1997;6:943-8.
74. Barnett YA, King CM. An investigation of antioxidant status, DNA repair capacity and mutation as a function of age in human. Mutat Res 1995;338: 115-28.
75. Trizna Z, Hsu TC, Schantz SP. Protective effects of vitamin E against bleomycin-induced genotoxicity in head and neck cancer patients in vitro. Anticancer Res 1992;12:325-8.
76. Trizna Z, Schantz SP, Lee JJ, Spitz MR, Goepfert H, Hsu TC, et al. In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients. Cancer Detect Prev 1993;17:575-83.
77. Kucuk O, Pung A, Franke AA, Custer LJ, Wilkens LR, Le Marchand L, et al. Correlations between mutagen sensitivity and plasma nutrient levels of healthy individuals. Cancer Epidemiol Biomarkers Prev 1995;4:217-21.
78. King TM, Trizna Z, Wu X, Amos CI, Fueger RH, Fueger JJ, et al. A clinical trial to evaluate the effect of vitamin C supplementation on in vitro mutagen sensitivity. Cancer Epidemiol Biomarkers Prev 1997;6:537-42.
79. Goodman MT, Hernandez B, Wilkens LR, Lee J, Le Marchand L, Liu LQ, et al. Effects of β-carotene and α-tocopherol on bleomycin-induced chromosomal damage. Cancer Epidemiol Biomarkers Prev 1998;7:113-7.
80. Hu JJ, Roush GC, Berwick M, Dubin N, Mahabir S, Chandiramani M, et al. Effects of dietary supplementation of alpha-tocopherol on plasma glutathione and DNA repair activities. Cancer Epidemiol Biomarkers Prev 1996;5:263-70.
81. DeFrank JS, Tang W, Powell SN. p53-null cells are more sensitive to UV light only in the presence of caffeine. Cancer Res 1996;56:5365-8.
82. Muller WU, Bauch T, Wojcik A, Bocker W, Streffer C. Comet assay studies indicate that the caffeine-mediated increase in radiation risk of embryos is due to inhibition of DNA repair. Mutagenesis 1996;11:57-60.
83. Link CJ Jr, Evans MK, Cook JA, Muldoon R, Stevnsner T, Bohr VA. Caffeine inhibits gene-specific repair of UV-induced DNA damage in hamster cells and in human xeroderma pigmentosum group C cells. Carcinogenesis 1995;16:1149-55.
84. Pero RW, Anderson MW, Doyle GA, Anna CH, Romagna F, Markowitz M, et al. Oxidative stress induces DNA damage and inhibits the repair of DNA lesions induced by N-acetoxy-2-acetylaminofluorene in human peripheral mononuclear leukocytes. Cancer Res 1990;50:4619-25.
85. Hsu TC, Furlong C. The role of ethanol in oncogenesis of the upper aerodigestive tract; inhibition of DNA repair. Anlicancer Res 1991;11: 1995-8.
86. Mohrenweiser HW, Jones IM. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat Res 1998;400:15-24.
87. Altschuler D, Kruglyak L, Lander E. Genetic polymorphisms and disease [letter]. N Engl J Med 1998;338:1626.
88. Mark SD. Defining and analyzing cohorts using molecular markers of cancer risk. J Cell Biochem Suppl 1996;25:69-79.
89. Chaney SG, Sancar A. DNA repair: enzymatic mechanisms and relevance to drug response. J Natl Cancer Inst 1996;88:1346-60.
90. Jelinksy SA, Samson LD. Global response of Saccharomyces cerevisiae to an alkylating agent. Proc Natl Acad Sci USA 1999;96:1486-91.
91. Cooper DA, Eldridge AL, Peters JC. Dietary carotenoids and lung cancer: a review of recent research. Nutr Rev 1999;57:133-45.
92. Paleologo M, van Schooten FS, Pavunello S, Kriek E, Zordan M, Clonfero E, et al. Detection of benzo(a)pyrene-diol-epoxide-DNA adducts in while blood cells of psoriatic patients treated with coal tar. Mutat Res 1992;281: 11-6.
93. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.